AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G/A] CASI Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Panacea Venture Healthcare Fund II, L.P.
Signature:By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang
Name/Title:James Huang, Founding Managing Partner
Date:07/23/2025
Panacea Venture Healthcare Fund II GP Company, Ltd.
Signature:By: Panacea Innovation Limited, its sole owner, /s/ James Huang
Name/Title:James Huang, Founding Managing Partner
Date:07/23/2025
Panacea Innovation Limited
Signature:/s/ James Huang
Name/Title:James Huang, Founding Managing Partner
Date:07/23/2025
James Huang
Signature:/s/ James Huang
Name/Title:James Huang
Date:07/23/2025
Casi Pharmaceuticals Inc

NASDAQ:CASI

CASI Rankings

CASI Latest News

CASI Latest SEC Filings

CASI Stock Data

34.55M
7.21M
48.39%
20.42%
0.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
China
ROCKVILLE